1. Chen D, Long H, Li S, Chen Y. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2024 report. Chinese General Practice. 2024;27(13).

2. Gale NS, Duckers JM, Enright S, Cockcroft JR, Shale DJ, Bolton CE. Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulm Med. 2011; 11(1): 20.

3. SpruitMA,Burtin Ch, Boever PD, Langer D, Vogiatzis I, Wouters EFM, et al. COPD and exercise: does it make a difference? Breathe (Sheff). 2016; 12(2): e38-49.

4. Kilpatrick DC, St Swierzko A, Matsushita M, Domzalska-Popadiuk I, Borkowska-Klos M, Szczapa J, et al. The relationship between FCN2 genotypes and serum ficolin-2 (L-ficolin) protein concentrations from a large cohort of neonates. Hum Immunol. 2013; 74(7): 867–71. doi.org/10.1016/j.humimm.2013.04.011

5. Nair RR, An JM, Kim J, Kim D. Review: Recent progress in fluorescent molecular systems for the detection of disease-related biomarkers in biofluids. Coord Chem Rev [Internet]. 2023; 494(215336):215336. doi.org/10.1016/j.ccr. 2023 .215336

6. Wei J, Xiong XF, Lin YH, Zheng BX, Cheng DY. Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis. Peer J. 2015;3:e1199. doi.org/10.7717/peerj.1199

7. Hladek M, Gill JM, Lai C, Bandeen-Roche K, Xue Q-L, Allen J, et al. High social coping self-efficacy associated with lower sweat interleukin-6 in older adults with chronic illness. J Appl Gerontol. 2022; 41(2): 581–9. doi.org/10.1177/07334648211006518

8. Huang AX, Lu LW, Liu WJ, Huang M. Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-α levels correlate with pulmonary function in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome. Med Sci Monit. 2016; 22: 2800–8. doi.org/10.12659/msm.896458

9. Jónsdóttir B, Jaworowski Å, San Miguel C, Melander O. IL-8 predicts early mortality in patients with acute hypercapnic respiratory failure treated with noninvasive positive pressure ventilation. BMC Pulm Med. 2017;17(1):35. doi.org/10.1186/s12890-017-0377-7

10. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014; 2014: 406960. doi.org/10.1155/2014/406960

11. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2008; 82(1): 251. doi.org/10.1016/j.ajhg.2007.12.007

12. Bowen TS, Aakerøy L, Eisenkolb S, Kunth P, Bakkerud F, Wohlwend M, et al. Exercise training reverses extrapulmonary impairments in smoke-exposed mice. Med Sci Sports Exerc. 2017; 49(5): 879–87. doi.org/10.1249/mss. 0000000000001195

13. Petersen A. Physical activity counteracts increased whole-body protein breakdown in chronic obstructive pulmonary disease patients. Scandinavian J Med Sci Sports. 2008;18:557–64.

14. Wang CH, Chou PC, Joa WC, Chen LF, Sheng TF, Ho SC, et al. Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot study. BMC Pulm Med. 2014;14(1):142. doi.org/10.1186/1471-2466-14-142

15. Costa D, Sanches Pereira do Nascimento E, Maria Sampaio Malosa L, Sobral Peixoto Souza F, Dultra Dias F, Leal Freitas Dantas Gomes E, et al. Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis [Internet]. 2015; 645. doi.org/10.2147/copd.s76216.

16. Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev [Internet]. 2018;27(149):180022. Available at: http://dx.doi.org/10.1183/16000617.0022-2018

17. Ryrsø CK, Thaning P, Siebenmann C, Lundby C, Lange P, Pedersen BK, et al. Effect of endurance versus resistance training on local muscle and systemic inflammation and oxidative stress in COPD. Scand J Med Sci Sports. 2018; 28(11): 2339–8. doi.org/10.1111/sms.13227

18. Bolton CE, Broekhuizen R, Ionescu AA, Nixon LS, Wouters EFM, Shale DJ, et al. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax. 2007; 62(2): 109–14. doi.org/10.1136/thx.2006.060368

19. Canavan J, Garrod R, Marshall J, Jackson D, Ansley P, Jewell A. Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation. Int J Chron Obstruct Pulmon Dis. 2007; 2(3): 347–53.

20. Silva BS de A, Lira FS, Rossi FE, Ramos D, Uzeloto JS, Freire APCF, et al. Inflammatory and metabolic responses to different resistance training on chronic obstructive pulmonary disease: A randomized control trial. Front Physiol. 2018; 9: 262. doi.org/10.3389/fphys.2018.00262

21. Wu LL, Lin ZK, Weng HD, Qi QF, Lu J, Liu KX. Effectiveness of meditative movement on COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018; 13: 1239–50. doi.org/10.2147/COPD.S159042

22. Ngai SPC, Jones AYM, Tam WWS. Tai Chi for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2016; 2016(6): CD009953.doi.org/10.1002/14651858.CD009953.pub2

23. Welte T. Optimising treatment for COPD-new strategies for combination therapy. Int J Clin Practice. 2009;63(8):1136–49.

24. Amin MN, Tarigan AP, Pradana A, Ashar T, Osareniro OE. Physical exercise and chicken egg white supplementation increase muscle mass of stable COPD patients. Narra J. 2024;4(1):e406. doi.org/10.52225/narra.v4i1.406

25. Sanguinetti CM. COPD: why, how, and when? Multidiscip Respir Med. 2015;11..

26. Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014; 2(3): 187–94. doi.org/10.1016/S2213-2600(13)70286-8.

27. Liu W, Liu XM, Huang YL, Yu PM, Zhang XW, Zhao C, et al. Tai Chi as a complementary exercise for pulmonary rehabilitation in chronic obstructive pulmonary disease: A randomised controlled trial. Complement Ther Med. 2023; 78(102977): 102977. doi.org/10.1016/j.ctim.2023.102977

28. Francisco de Lima F, Marçal Camillo CA, Grigoletto I, Uzeloto J, Marques Vanderlei F, Ramos D, et al. Combining functional exercises with exercise training in COPD: a randomized controlled trial. Physiother Theory Pract. 2024; 40(5): 952–61. doi.org/10.1080/09593985. 2022.2148146

29. Hirai DM, Jones JH, Zelt JT, da Silva ML, Bentley RF, Edgett BA, et al. Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease. J Appl Physiol. 2017; 122(5): 1351–61. doi.org/10.1152/japplphysiol.00990. 2016

30. Aliniya N, Elmieh A, Fadaei Chafy MR. Interaction effect of combined exercise and supplementation with portulaca oleracea on liver enzymes in obese postmenopausal women with non-alcoholic fatty liver disease. Complementary Med J. 2020. 10(1): 68-79.

31. Salve VT, Atram JS. N-acetylcysteine combined with home based physical activity: Effect on health related Quality of life in stable COPD patients- A randomised controlled trial. J Clin Diagn Res 2016; 10(12): OC16–9. doi.org/10.7860/JCDR/2016/23668.8980

32. Kazeminasab F, Behzanejad N, Khalafi M. Impact of exercise training on inflammatory markers in adult and elderly patients with chronic obstructive pulmonary disease: A Systematic review and meta-analysis. J Ilam Univ Med Sci. 2024; 32(2): 1–16.

33. El-Kader A, Al-Jiffri OH, Al-Shreef FM. Plasma inflammatory biomarkers response to aerobic versus resisted exercise training for chronic obstructive pulmonary disease patients. African Health Sci. 2016; 16: 507–15.

34. Kikanlu B. He effect of combined exercises on the level of interleukin-6 and some pulmonary parameters in chemical veterans exposed to mustard gasNafs Quarterly. 2021;7.

35. da Silva IRV, de Araujo CLP, Dorneles GP, Peres A, Bard AL, Reinaldo G, et al. Exercise-modulated epigenetic markers and inflammatory response in COPD individuals: A pilot study. Respir Physiol Neurobiol. 2017; 242: 89–95. doi.org/10.1016/j.resp.2017.04.004

36. Lee T-M, Lin M-S, Chang N-C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardio. 2008; 101(4): 530–5. doi.org/10.1016/j.amjcard.2007.09.102

37. Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014; 145(3): 542–50. doi.org/10.1378/chest.13-1052

38. Amini M. Effect of Diaphragmatic Respiratory Training on Some Pulmonary Indexes in Older People With Chronic Obstructive Pulmonary Disease. Salmand: Iran J Ageing. 2019; 14(3): 332–41.

39. Shu C, Feng S, Cui Q, Cheng S, Wang Y. Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis. Ann Palliat Med [Internet]. 2021; 10(7): 7468–78. Available at: http://dx.doi.org/10.21037/apm-21-640

40. Vkds L, De Paula FA, Lima LP, Santos J, Santos JM, Viegas ÂA. Plasma levels of myokines and inflammatory markers are related with functional and respiratory performance in older adults with COPD and sarcopenia. Experimental Gerontol. 2022; 164.

41. Covey MK, Collins EG, Reynertson SI, Dilling DF. Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD. Respir Med [Internet]. 2014;108(8):1141–52.

42. Kawagoshi A, Kiyokawa N, Sugawara K, Takahashi H, Sakata S, Satake M, et al. Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease. Respir Med. 2015; 109(3): 364–71. doi.org/10.1016/j.rmed. 2015.01.008.

43. Duan W, Zeng D, Huang J, Gu J, Li S, Zhou W, et al. Effect of modified Total Body Recumbent Stepper training on exercise capacity and thioredoxin in COPD: a randomized clinical trial. Sci Rep. 2022; 12(1): 11139. doi.org/10.1038/s41598-022-15466-2

44. Mccarthy B. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Systematic Rev. 2015.

45. Jamali F, Ahmadzadeh A, Sahraei Z, Salamzadeh J. Study of the effects of N-acetylcysteine on inflammatory biomarkers and disease activity score in patients with rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2021;20(5):574–83..doi.org/10.18502/ijaai.v20i5.7407

46. Larki RA. Effect of n-acetylcysteine on inflammatory and biochemical markers of hemodialysis patients: A randomized controlled trial. Acta Medica Iranica. 2019; 57(1):1-6

47. Moitra S. N-acetylcysteine (NAC) in COPD: benefits often lost in trials. QJM [Internet]. 2019;112(5):387–8. Available from: http://dx.doi.org/10.1093/qjmed/hcy166

48. Salve VT, Atram JS. N-acetylcysteine combined with home based physical activity: effect on health related quality of life in stable COPD patients-a randomised controlled trial. J Clin Diagnostic Res. 2016;10(12).

49. Sanguinetti CM. N-acetylcysteine in COPD: why, how, and when? Multidiscip Respir Med. 2015;11(1):8.doi.org/10.1186/s40248-016-0039-2

50. Stav D, Raz M. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest. 2009;136(2):381–6. doi.org/10.1378/chest.09-0421.